Beta Bionics (NASDAQ:BBNX) Rating Increased to Strong-Buy at Leerink Partnrs
Leerink Partnrs upgraded shares of Beta Bionics (NASDAQ:BBNX – Free Report) to a strong-buy rating in a research report sent to investors on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Beta Bionics’ Q4 2024 earnings at ($0.42) EPS, FY2024 earnings at ($1.66) EPS, Q1 2025 earnings at ($0.50) EPS, Q2 2025 earnings at […]
Leerink Partnrs upgraded shares of Beta Bionics (NASDAQ:BBNX – Free Report) to a strong-buy rating in a research report sent to investors on Monday morning,Zacks.com reports. Leerink Partnrs also issued estimates for Beta Bionics’ Q4 2024 earnings at ($0.42) EPS, FY2024 earnings at ($1.66) EPS, Q1 2025 earnings at ($0.50) EPS, Q2 2025 earnings at […]
